NEWS: 公告在東京證券交易所JASDAQ標準市場新上市


靜脈曲張治療設備市場 - 預測(2021年∼2026年)

Varicose Veins Treatment Device Market - Forecasts from 2021 to 2026

出版商 Knowledge Sourcing Intelligence 商品編碼 1023175
出版日期 內容資訊 英文 114 Pages
商品交期: 最快1-2個工作天內
靜脈曲張治療設備市場 - 預測(2021年∼2026年) Varicose Veins Treatment Device Market - Forecasts from 2021 to 2026
出版日期: 2021年07月06日內容資訊: 英文 114 Pages





第1章 簡介

  • 市場定義
  • 市場區隔

第2章 調查手法

  • 調查資料
  • 前提條件

第3章 摘要整理

  • 調查的重點

第4章 市場動態

  • 市場推動因素
  • 市場阻礙因素
  • 波特的五力分析
    • 供給企業的交易
    • 購買企業的交易
    • 新加入業者的威脅
    • 替代品的威脅
    • 產業的競爭企業間的競爭關係
  • 產業的價值鏈分析

第5章 設備的各類型:靜脈曲張治療市場分析

  • 簡介
  • 靜脈封閉設備
  • 外科用設備
  • 切除設備

第6章 各治療法:靜脈曲張治療市場分析

  • 簡介
  • 硬化療法
  • 靜脈內雷射治療(EVLT)
  • 無線電趨勢燒灼術療法(RFA)
  • 外科的結警察 & 汽提

第7章 各終端用戶:全球靜脈曲張治療市場分析

  • 簡介
  • 醫院和診所
  • 門診病人診療中心

第8章 各地區:全球靜脈曲張治療市場分析

  • 簡介
  • 北美
    • 美國
    • 加拿大
    • 墨西哥
  • 南美
    • 巴西
    • 阿根廷
    • 其他
  • 歐洲
    • 英國
    • 法國
    • 德國
    • 義大利
    • 其他
  • 中東和非洲
  • 亞太地區
    • 日本
    • 中國
    • 印度
    • 泰國
    • 台灣
    • 印尼
    • 其他

第9章 競爭環境與分析

  • 主要企業策略分析
  • 新興企業和市場收益性
  • 合併,收購,協定,共同研究
  • 供應商競爭 力量矩陣

第10章 企業簡介

  • INTERmedic
  • VVT Med
  • Miravas
  • Biolitic AG
  • Medtronic
  • AngioDynamics Inc.
  • Eufoton S.R.L
  • Teleflex Incorporated
  • GIGAA Laser
  • Alma
Product Code: KSI061611755

The varicose veins treatment device market is projected to grow at a CAGR of 4.87% to reach US$1,332.297 million by 2026, from US$954.826 million in 2019. Varicose veins are essentially twisted and enlarged veins. The veins present in the legs can most commonly become varicose. That is because standing and walking upright creates pressure in the veins of the lower part of the body. It can cause a lot of pain and discomfort. Damage valves often lead to varicose veins. The problem is most commonly found in women, especially in pregnant women and in the elderly population. The signs of having varicose veins include:

  • Veins that are blue in colour.
  • Veins that are twisted and budging out.
  • Cramps in muscles and swelling in the lower part of the leg.
  • Itching around one or more than one vein.

A major reason for the growth of this market is the rapid upward trend in global wealth.

Global wealth has increased significantly over the past two decades. The Asia Pacific market is expected to witness rapid growth in the varicose veins treatment device market. The region has witnessed significant growth in disposable income over the years. Vietnam is likely to be the top performer. According to the world bank, "more than 800 million people have been lifted out of poverty in China." Bangladesh and India are projected to witness enormous growth in per capita income. According to the World Bank, GDP per capita growth in North America stood at 1.5 percent in 2019. The highest growth was witnessed by the USA (1.7%). Similarly, the growth stood at 1.6 percent in the European countries. There exists a positive relationship between income and health. As the global income is witnessing an upward trend, people have better access to care. The valuation of risk increases with income. According to the world health organization, "Spending on health is growing faster than the rest of the global economy, accounting for 10% of global gross domestic product (GDP)." Moreover, middle-income countries are spending more on health as compared to high-income countries. For the middle-income countries, the health expenditure is growing on an average of 6 percent annually whereas that of high-income countries is amassing on an average of 4 percent. The rapidly rising income is expected to boost the growth of the Varicose veins treatment devices market.

Technological innovation is expected to drive the demand for this market in the forecast period.

Technological advancement in the devices used for the varicose veins treatment is expected to spur market growth. Innovation in science is helping millions of people suffering from the varicose veins problem. Millions of people can fight the problem with the help of invasive treatment called radiofrequency (RF) technology. The innovation locks the damaged veins with low-temperature radiofrequency energy. New technology is invented in Belgium for the treatment of varicose veins. It thermally district's the small veins. Theraclion's SONOVEIN was discovered in 2019 for the varicose vein treatment. It allows treating the problem from outside the body and hence does not require any operation theatre. Many hospitals have also incorporated improved imaging cloud to assist doctors to further improve the treatment. These technological advances are patient-friendly with better safety measures and help in treating the problem in an improved manner. Therefore, technological advancements are expected to fuel the growth of the market.

The growth of the elderly population is anticipated to fuel the growth of this market.

According to the World Health Organisation, in 2018, more than 125 million people were aged 80 years or older. The number of people aged 60 years and older accounted for 1 billion people. The rate of population aging is increasing dramatically around the world. According to World Health Organisation,

"By 2050, the world's population aged 60 years and older is expected to total 2 billion and there will be almost this many (120 million) living in China alone of the age group 80 years and above, and 434 million people in this age group worldwide." The risk of varicose vein problems increases with age. Aging often leads to wear and tear on the valves that hamper the blood flow. The blood collects in the veins instead of flowing back to the heart. This makes the problem even more severe. Also, women are most likely to develop the condition. As the problem is spurting, and the population is aging promptly, people are spending more on the treatment. This, in turn, will contribute to the growth of the varicose veins treatment devices market.

Market Segmentation:

  • By Devices

Venous Closure Devices

Surgical Devices

Ablation Devices

  • By Treatment


Endovenous Laser Therapy (EVLT)

Radio Frequency Ablation (RFA)

Surgical Ligation and Stripping

  • By End-User

Hospitals and clinics

Ambulatory care centre

  • By Geography

North America

  • USA
  • Canada
  • Mexico

South America

  • Brazil
  • Argentina
  • Others


  • UK
  • Germany
  • France
  • Italy
  • Others

The Middle East and Africa

Asia Pacific

  • Japan
  • China
  • India
  • Thailand
  • Taiwan
  • Indonesia
  • Others

Table of Contents

1. Introduction

  • 1.1. Market Definition
  • 1.2. Market Segmentation

2. Research Methodology

  • 2.1. Research Data
  • 2.2. Assumptions

3. Executive Summary

  • 3.1. Research Highlights

4. Market Dynamics

  • 4.1. Market Drivers
  • 4.2. Market Restraints
  • 4.3. Porters Five Forces Analysis
    • 4.3.1. Bargaining Power of Suppliers
    • 4.3.2. Bargaining Power of Buyers
    • 4.3.3. The threat of New Entrants
    • 4.3.4. Threat of Substitutes
    • 4.3.5. Competitive Rivalry in the Industry
  • 4.4. Industry Value Chain Analysis

5. Varicose Veins Treatment Market Analysis, By Devices

  • 5.1. Introduction
  • 5.2. Venous Closure Devices
  • 5.3. Surgical Devices
  • 5.4. Ablation Devices

6. Varicose Veins Treatment Market Analysis, By Treatment

  • 6.1. Introduction
  • 6.2. Sclerotherapy
  • 6.3. Endovenous Laser Therapy (EVLT)
  • 6.4. Radio Frequency Ablation (RFA)
  • 6.5. Surgical Ligation & Stripping

7. Global Varicose Veins Treatment Market Analysis, By End-Users

  • 7.1. Introduction
  • 7.2. Hospitals & Clinics
  • 7.3. Ambulatory Care Center

8. Global Varicose Veins Treatment Market Analysis, By Geography

  • 8.1. Introduction
  • 8.2. North America
    • 8.2.1. United States
    • 8.2.2. Canada
    • 8.2.3. Mexico
  • 8.3. South America
    • 8.3.1. Brazil
    • 8.3.2. Argentina
    • 8.3.3. Others
  • 8.4. Europe
    • 8.4.1. UK
    • 8.4.2. France
    • 8.4.3. Germany
    • 8.4.4. Italy
    • 8.4.5. Others
  • 8.5. The Middle East and Africa
  • 8.6. Asia Pacific
    • 8.6.1. Japan
    • 8.6.2. China
    • 8.6.3. India
    • 8.6.4. Thailand
    • 8.6.5. Taiwan
    • 8.6.6. Indonesia
    • 8.6.7. Others

9. Competitive Environment and Analysis

  • 9.1. Major Players and Strategy Analysis
  • 9.2. Emerging Players and Market Lucrativeness
  • 9.3. Mergers, Acquisitions, Agreements, and Collaborations
  • 9.4. Vendor Competitiveness Matrix

10. Company Profiles

  • 10.1. INTERmedic
  • 10.2. VVT Med
  • 10.3. Miravas
  • 10.4. Biolitic AG
  • 10.5. Medtronic
  • 10.6. AngioDynamics Inc.
  • 10.7. Eufoton S.R.L
  • 10.8. Teleflex Incorporated
  • 10.9. GIGAA Laser
  • 10.10. Alma